0

Gastroenterology/Hepatology Collection
 221-240 of 2622 Articles
Editorials |  15 October 2002
Rare Outcomes, Common Treatments: Analytic Strategies Using Propensity Scores
Leonard E. Braitman, PhD; Paul R. Rosenbaum, PhD
Ann Intern Med. 2002;137(8):693-695. doi:10.7326/0003-4819-137-8-200210150-00015
Articles |  15 October 2002
Short-Course Rifampin and Pyrazinamide Compared with Isoniazid for Latent Tuberculosis Infection: A Multicenter Clinical Trial
Robert M. Jasmer, MD; Jussi J. Saukkonen, MD; Henry M. Blumberg, MD; et al.
Ann Intern Med. 2002;137(8):640-647. doi:10.7326/0003-4819-137-8-200210150-00007
Reviews |  1 October 2002
The Genetics of Colorectal Cancer
Paula M. Calvert, MD; Harold Frucht, MD
Ann Intern Med. 2002;137(7):603-612. doi:10.7326/0003-4819-137-7-200210010-00012
Articles |  1 October 2002
Prevalence of bcl-2 Rearrangement in Patients with Hepatitis C Virus–Related Mixed Cryoglobulinemia with or without B-Cell Lymphomas
Anna Linda Zignego, MD, PhD; Clodoveo Ferri, MD; Francesca Giannelli, PhD; et al.
Ann Intern Med. 2002;137(7):571-580. doi:10.7326/0003-4819-137-7-200210010-00008
Articles |  16 July 2002 FREE
Cost-Effectiveness Analyses of Colorectal Cancer Screening: A Systematic Review for the U.S. Preventive Services Task Force
Michael Pignone, MD, MPH; Somnath Saha, MD, MPH; Tom Hoerger, PhD; et al.
Ann Intern Med. 2002;137(2):96-104. doi:10.7326/0003-4819-137-2-200207160-00007
Editorials |  2 July 2002
Alanine Aminotransferase Levels: What's Normal?
Marshall M. Kaplan, MD
Ann Intern Med. 2002;137(1):49-51. doi:10.7326/0003-4819-137-1-200207020-00012
Articles |  2 July 2002
Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels
Daniele Prati, MD; Emanuela Taioli, MD, PhD; Alberto Zanella, MD; et al.
Ann Intern Med. 2002;137(1):1-10. doi:10.7326/0003-4819-137-1-200207020-00006
Academia and the Profession |  18 June 2002
Truth Survival in Clinical Research: An Evidence-Based Requiem?
Thierry Poynard, MD, PhD; Mona Munteanu, MD; Vlad Ratziu, MD; et al.
Ann Intern Med. 2002;136(12):888-895. doi:10.7326/0003-4819-136-12-200206180-00010
Reviews |  21 May 2002
Approach to the Patient with Chronic Hepatitis C Virus Infection
Steven K. Herrine, MD
Ann Intern Med. 2002;136(10):747-757. doi:10.7326/0003-4819-136-10-200205210-00010
Brief Communications |  7 May 2002
Reversibility of Cirrhosis in Patients Cured of Thalassemia by Bone Marrow Transplantation
Pietro Muretto, MD; Emanuele Angelucci, MD; Guido Lucarelli, MD
Ann Intern Med. 2002;136(9):667-672. doi:10.7326/0003-4819-136-9-200205070-00009
Articles |  7 May 2002
Public Expectations and Attitudes for Annual Physical Examinations and Testing
Sylvia K. Oboler, MD; Allan V. Prochazka, MD, MSc; Ralph Gonzales, MD, MPH; et al.
Ann Intern Med. 2002;136(9):652-659. doi:10.7326/0003-4819-136-9-200205070-00007
Resource Corner |  May/Jun 2002
The Desktop Guide to Complementary and Alternative Medicine: An Evidence-based Approach
Kumanan Wilson, MD
Ann Intern Med. 2002;136(3):A14. doi:10.7326/ACPJC-2002-136-3-A14
Therapeutics |  May/Jun 2002
Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis
W. A. Hoogerwerf, MD; P. Jay Pasricha, MD
Ann Intern Med. 2002;136(3):95. doi:10.7326/ACPJC-2002-136-3-095
Therapeutics |  May/Jun 2002
Nadolol and isosorbide prevented recurrent variceal bleeding better than did endoscopic ligation in cirrhosis
Hubert H. Nietsch, MD; Kris V. Kowdley, MD
Ann Intern Med. 2002;136(3):94. doi:10.7326/ACPJC-2002-136-3-094
Therapeutics |  May/Jun 2002
Enteral nutrition led to fewer postoperative complications than did parenteral feeding in gastrointestinal cancer
Ronald L. Koretz, MD
Ann Intern Med. 2002;136(3):93. doi:10.7326/ACPJC-2002-136-3-093
Therapeutics |  May/Jun 2002
Olsalazine was not better than placebo in maintaining remission in inactive Crohn disease
Gurinder Luthra, MD; P. Jay Pasricha, MD
Ann Intern Med. 2002;136(3):92. doi:10.7326/ACPJC-2002-136-3-092
Therapeutics |  May/Jun 2002
Review: Hemoccult screening reduces death from colorectal cancer in average-risk patients > 50 years of age
Robert Fletcher, MD, MSc
Ann Intern Med. 2002;136(3):91. doi:10.7326/ACPJC-2002-136-3-091
Brief Communications |  16 April 2002
Severe Hepatotoxicity Associated with the Dietary Supplement LipoKinetix
Joya T. Favreau, MD; Mina L. Ryu, MD; Glenn Braunstein, MD; et al.
Ann Intern Med. 2002;136(8):590-595. doi:10.7326/0003-4819-136-8-200204160-00008
Editorials |  19 March 2002
“Did This Drug Cause My Patient's Hepatitis?” and Related Questions
David W. Nierenberg, MD
Ann Intern Med. 2002;136(6):480-483. doi:10.7326/0003-4819-136-6-200203190-00013
Ideas and Opinions |  19 March 2002
Deconstructing the Placebo Effect and Finding the Meaning Response
Daniel E. Moerman, PhD; Wayne B. Jonas, MD
Ann Intern Med. 2002;136(6):471-476. doi:10.7326/0003-4819-136-6-200203190-00011
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)